Kamel Laribi
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Genetics 55
- Chronic Lymphocytic Leukemia Research 41
- Myeloproliferative Neoplasms: Diagnosis and Treatment 13
- Hematology 63
- Acute Myeloid Leukemia Research 27
- Multiple Myeloma Research and Treatments 25
- Erythropoietin and Anemia Treatment 5
- Platelet Disorders and Treatments 4
- Co-authors
- Alix Baugier de Materre (17 shared papers)Paul Cheng (2 shared papers)Wojciech Maciej Legiec (2 shared papers)Noopur S. Raje (2 shared papers)Brian G.M. Durie (2 shared papers)Marta Krejčí (2 shared papers)Evangelos Terpos (2 shared papers)Wolfgang Willenbacher (2 shared papers)
- Journals
- Blood (35 papers)British Journal of Haematology (10 papers)Blood Advances (10 papers)Leukemia (9 papers)Haematologica (8 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Kamel Laribi
142 papers receiving 4.9k citations
Kamel Laribi's Hit Papers
Peers
Comparison fields: 5 of 83
- Hematology 2.2k
- Genetics 985
- Pathology and Forensic Medicine 657
- Oncology 519
- Neurology 211
Countries citing papers authored by Kamel Laribi
This map shows the geographic impact of Kamel Laribi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamel Laribi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamel Laribi more than expected).
Fields of papers citing papers by Kamel Laribi
This network shows the impact of papers produced by Kamel Laribi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamel Laribi. The network helps show where Kamel Laribi may publish in the future.
Co-authors
The 25 scholars most cited alongside Kamel Laribi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial Hit paper breakdown → | 2020 | 599 |
| 2 | 2018 | 347 | |
| 3 | 2014 | 291 | |
| 4 | 2017 | 265 | |
| 5 | 2018 | 254 | |
| 6 | 2016 | 196 | |
| 7 | 2020 | 183 | |
| 8 | 2011 | 178 | |
| 9 | Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study Hit paper breakdown → | 2023 | 146 |
| 10 | 2017 | 132 | |
| 11 | 2015 | 107 | |
| 12 | 2022 | 105 | |
| 13 | 2019 | 80 | |
| 14 | 2001 | 75 | |
| 15 | 2018 | 69 | |
| 16 | Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial Hit paper breakdown → | 2024 | 68 |
| 17 | 2013 | 65 | |
| 18 | 2018 | 65 | |
| 19 | 2017 | 56 | |
| 20 | 2020 | 56 |
About Kamel Laribi
Kamel Laribi is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Dermatology and Oncology, having authored 157 papers that have together received 5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (41 papers), Lymphoma Diagnosis and Treatment (31 papers), Acute Myeloid Leukemia Research (27 papers), Multiple Myeloma Research and Treatments (25 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Erythropoietin and Anemia Treatment (5 papers), Histiocytic Disorders and Treatments (4 papers) and Platelet Disorders and Treatments (4 papers). The work is most often cited by research in Hematology (2.2k citations), Genetics (985 citations), Pathology and Forensic Medicine (657 citations), Oncology (519 citations) and Neurology (211 citations). Kamel Laribi has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Alix Baugier de Materre, Paul Cheng, Wojciech Maciej Legiec, Noopur S. Raje, Brian G.M. Durie, Marta Krejčí, Evangelos Terpos, Wolfgang Willenbacher, Kazuyuki Shimizu and Ramón García‐Sánz. Their work appears in journals such as Blood, British Journal of Haematology, Blood Advances, Leukemia and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.